Walnut Creek, CANCT07296276Now EnrollingIRB Ready

Type 1 Diabetes Mellitus Clinical Trial in Walnut Creek, CA

Access cutting-edge type 1 diabetes mellitus treatment through this clinical trial at a research site in Walnut Creek. Study-provided care at no cost to qualified participants.

Sponsored by i-SENS, Inc.

Quick Self-Assessment

See if you qualify for this Walnut Creek location

Preparing your pre-screening questions…

Expert Care in Walnut Creek

Access type 1 diabetes mellitus specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related type 1 diabetes mellitus treatment provided free

Apply for This Walnut Creek Location

Check if you qualify for this type 1 diabetes mellitus clinical trial in Walnut Creek, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Walnut Creek

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Walnut Creek site if eligible
  4. 4Begin participation

About This Type 1 Diabetes Mellitus Study in Walnut Creek

This is a prospective, single arm, open-label, interventional, pilot study to evaluate the accuracy and precision of the continuous glucose monitoring (CGM) system of i-SENS, Inc., CareSens Air 3, in adult patients with type 1 diabetes.

Sponsor: i-SENS, Inc.

Who Can Participate

Inclusion Criteria

Adults who are 18-65 years of age, inclusive
Patients with type 1 diabetes who use intensive insulin therapy (multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII) including users of systems with continuous glucose monitoring (CGM) driven automatic adjustment of insulin doses for at least 3 months
Patients who voluntarily decide to participate in the study and provide written informed consent

Exclusion Criteria

The following abnormal skin or skin diseases or skin alterations at the CGM sensor attachment or insertion site: Severe psoriasis, recent burn injury or severe sunburn, severe eczema, severe scar, extensive tattoo, dermatitis herpetiformis, severe rash, Staphylococcus aureus infection.
Allergic contact dermatitis to medical adhesives.
History of frequent catheter abscesses associated with pump therapy.
Severe hypoglycemia events within 3 months prior to screening. Severe hypoglycemia is defined as loss of consciousness or seizure requiring emergency medical treatment due to hypoglycemia.
Hypoglycemia unawareness.
Conditions that predispose to hypoglycemia including inadequately treated thyroid and adrenal disease.
Participants with diabetic ketoacidosis within 3 months prior to screening.
History of epilepsy or syncope within 6 months prior to screening.
Unstable vascular diseases (defined by event or increasing symptoms in the last 6 months) or with insufficient therapy, including: Stroke, transitory cerebral ischemia, ischemic heart disease, peripheral vascular disease, and serious arrhythmia.
Patients with anemia (hemoglobin below normal range).
Patients scheduled for X-ray, MRI, CT or diathermy during the study.
Pregnant or lactating women or those who plan to become pregnant or do not agree to use an adequate method of contraception during the study.
Patients who are currently participating or participated within 2 weeks prior to screening in another study or plan to participate in another study that in the opinion of the investigator would affect the safety of the study participant or the study result.
Patients unwilling to abstain from ingesting the foodstuffs listed in Appendix 3 in excess of the allowed amounts.
Patients with cognitive impairment or who are not suitable for this study or may be at increased risk associated with study participation in the opinion of the investigator.
Wearing of a pace maker or other comparable medical devices.
HbA1c \>9.5%.
Dependency from the sponsor or the clinical investigator.
Unwillingness and/or inability to comply with study procedures.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Walnut Creek?

Yes, this clinical trial (NCT07296276) has an active research site in Walnut Creek, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Type 1 Diabetes Mellitus Treatment Options in Walnut Creek, CA

If you're searching for type 1 diabetes mellitus treatment options in Walnut Creek, CA, this clinical trial (NCT07296276) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Walnut Creek research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 1 diabetes mellitus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all type 1 diabetes mellitus clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Walnut Creek, CA

See all pulmonary embolism clinical trials recruiting in Walnut Creek — not just this study.

Browse Pulmonary Embolism Trials in Walnut Creek →

Browse More Trials by Condition

Pulmonary Embolism TrialsEssential Tremor TrialsType 2 Diabetes TrialsType 1 Diabetes TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Walnut Creek?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Walnut Creek, CA